Back to search
FDAFDA · Food and drugs·Recall number D-1226-2014

Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.

Published April 16, 2014 · Recall initiated: March 25, 2014

Summary

FDA records drug Class III recall D-1226-2014, published April 16, 2014 and initiated March 25, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 237,850 ampoules; Lot: Lot: 221303A, 1OCT2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Missing label; ampoules are missing the immediate container label

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot: 221303A, 1OCT2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL. recalled?

Yes. FDA published recall D-1226-2014 on April 16, 2014. Reported hazard: Labeling; Missing label; ampoules are missing the immediate container label

What should I do if I have this product?

Voluntary: Firm initiated · Letter